Controversy Surrounds Proposed Ban on Menthol Cigarettes in US

Jul.11.2022
Controversy Surrounds Proposed Ban on Menthol Cigarettes in US
The FDA received 110,000 comments on proposed rules to end menthol cigarette sales and 60,000 on flavored cigar bans.

The US Food and Drug Administration has received over 110,000 comments regarding the proposed rule to end the sale of menthol-flavored cigarettes, as well as nearly 60,000 comments regarding the proposed rule to ban the description of cigar flavors.


Many individuals and business owners have written letters in opposition to the ban, claiming that it will result in layoffs.


A tobacco retailer in Florida wrote, "If implemented, this proposal could harm American retailers and wholesalers and directly impact my bottom line. The target of this ban is a significant portion of my income; menthol cigarettes alone account for 36% of all cigarette sales in the US. Additionally, adult customers who purchase menthol cigarettes also happen to buy gasoline, food, and other items from my store.


Thousands of online submissions came from menthol cigarette smokers, who believe that the proposed restrictions are an unfair attack on personal freedom.


A respondent wrote, "This regulation goes far beyond the government's authority over the American people. We have age restrictions for a reason, and once you reach that age, you should be able to choose to use any legal product you want.


Others support the proposal, stating that removing menthol and other flavorings would improve health and help address racial injustice.


Kaelor Gordon stated that banning menthol in cigarettes is a necessary step towards promoting health fairness and improving overall health. They added that unfortunately, this substance unfairly bears the burden of smoking-related illnesses and deaths, so banning menthol aligns with the current strong anti-racism and health fairness culture we have today.


The FDA has extended the comment period from July 5, 2022, to August 2, 2022.


As an AI language model, I do not understand the context of the text to be translated. Please provide me with the original text to further assist you.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

 FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
The U.S. Food and Drug Administration (FDA) has initiated scientific review of renewal applications for 22nd Century Group’s VLN reduced-nicotine cigarettes under the Modified Risk Tobacco Product (MRTP) pathway, with current authorizations set to expire in December 2026.
News
May.13
Exclusive|Logistics Operators Warn of Possible New U.S. Border Crackdown on Illicit Vapes
Exclusive|Logistics Operators Warn of Possible New U.S. Border Crackdown on Illicit Vapes
Recent inspections and cargo disruption have led some logistics operators in the China-U.S. vape trade to see early signs of another U.S. border crackdown on illicit e-cigarettes. With late April to early May viewed as a key risk window, the market is watching closely. The bigger question is not only whether enforcement will tighten, but whether it can be sustained.
Special Report
Apr.09
Spanish Congress Health Committee Approves Motion to Restrict Vape and Nicotine Pouch Sales to Authorized Channels
Spanish Congress Health Committee Approves Motion to Restrict Vape and Nicotine Pouch Sales to Authorized Channels
Spain’s Congress Health Committee has approved a non-binding motion calling for the sale of vapes, nicotine pouches, and related products to be limited to regulated authorized channels, excluding internet sales and non-specialized stores. The motion was introduced by the Socialist Parliamentary Group and approved after a negotiated text with the Popular Party.
Apr.15 by 2FIRSTS.ai
Russian Vape Industry Proposes State Monopoly on E-Liquid Production as Alternative to Ban
Russian Vape Industry Proposes State Monopoly on E-Liquid Production as Alternative to Ban
Russian business groups are trying to persuade the authorities to abandon plans to ban the sale of e-cigarettes and related liquids at both the federal and regional levels.
Apr.03 by 2FIRSTS.ai
U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Dick Durbin on May 13 criticized the Trump Administration’s Food and Drug Administration for approving the sale and marketing of fruit-flavored e-cigarettes for the first time, while also allowing some illegal vaping products to remain on the market. He also linked the regulatory shift to the departure of FDA Commissioner Marty Makary, saying White House pressure on regulators to approve tobacco product applications could create serious public-health consequences.
Regulations
May.15
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
British American Tobacco (BAT) shares rose sharply on May 12 after the U.S. Food and Drug Administration signaled it would deprioritize enforcement against certain unauthorized e-cigarette and nicotine pouch products with accepted premarket applications. Investors viewed the move as favoring established players such as BAT’s Vuse and Velo brands.
BAT
May.13